Briviact

Medicinal product

(Invented) name

Briviact

Active substance (s)

Brivaracetamas

Strength

75 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N03AX23, Brivaracetam

Marketing authorisation holder

UCB Pharma S.A., Belgija

Date of authorisation

2016-01-14

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Brivaracetamas	75 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
65035	79531	1079531	lizdinė plokštelė	N14		Receptinis	EU/1/15/1073/013	Netiekiama	-	-	No	-	-
65036	79532	1079532	lizdinė plokštelė	N56		Receptinis	EU/1/15/1073/014	Netiekiama	-	-	No	-	-
65037	79533	1079533	dalomoji lizdinė plokštelė	N100x1		Receptinis	EU/1/15/1073/015	Netiekiama	-	-	No	-	-
65038	79534	1079534	lizdinė plokštelė	N168 (3x56) (sudėtinė)		Receptinis	EU/1/15/1073/016	Netiekiama	-	-	No	-	-
65983	80497	1080497	dalomoji lizdinė plokštelė	N14x1		Receptinis	EU/1/15/1073/026	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2016-01-14	Registruotas